Multicenter phase II trial of brequinar sodium in patients with advanced squamous-cell carcinoma of the head and neck
Susan G. Urba(University of Michigan), John W. Gyves(DuPont (United States)), C. Cripps(Canadian Partnership Against Cancer), R Carlson(DuPont (United States)), David B. Adams(Medical University of South Carolina), Antonio J Grillo-López(Roche (Switzerland)), Francisco Robert(University of Alabama at Birmingham), E Vélez-García(Breast Center), J. H. Doroshow(City Of Hope National Medical Center), B.K. Dallaire
Cited by 43
Related Papers
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.9k
Randomized Controlled Trial of Yttrium-90–Labeled Ibritumomab Tiuxetan Radioimmunotherapy Versus Rituximab Immunotherapy for Patients With Relapsed or Refractory Low-Grade, Follicular, or Transformed B-Cell Non-Hodgkin’s Lymphoma
|Journal of Clinical Oncology|2002|1.2k
Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.
|Journal of Clinical Oncology|1997|652
PANCREOX: A Randomized Phase III Study of Fluorouracil/Leucovorin With or Without Oxaliplatin for Second-Line Advanced Pancreatic Cancer in Patients Who Have Received Gemcitabine-Based Chemotherapy
|Journal of Clinical Oncology|2016|291
Single-Cycle Induction Chemotherapy Selects Patients With Advanced Laryngeal Cancer for Combined Chemoradiation: A New Treatment Paradigm
|Journal of Clinical Oncology|2005|267